Tacticath endosense study

TactiCath™ Quartz Contact Force Ablation Catheter

★ ★ ★ ☆ ☆

The TOCCASTAR trial (TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation) is the only prospective, randomized, controlled, multicenter study conducted to date to evaluate the safety and effectiveness of a contact force sensing ablation catheter for the treatment of symptomatic paroxysmal AF. 5. Key Takeaways:

TactiCath™ Quartz Contact Force Ablation Catheter

TactiCath™ Family of Contact Force Ablation Catheters ...

★ ★ ☆ ☆ ☆

TactiCath™ and TactiCath™ Quartz contact force ablation catheter clinical data are applicable to the TactiCath™ ablation catheter, Sensor Enabled as mechanical/function testing and preclinical studies have demonstrated equivalent performance and safety profile. See Abbott, data on file, Report 90195941.

TactiCath™ Family of Contact Force Ablation Catheters ...

Endosense Announces 12-Month TOCCATA Study Data ...

★ ★ ★ ☆ ☆

5/13/2010 · Endosense announces 12-month TOCCATA study data reinforcing clinical benefit of the TactiCath. The data was released at Heart Rhythm 2010 in Denver.

Endosense Announces 12-Month TOCCATA Study Data ...

Endosense Completes Enrollment in EFFICAS I Clinical Study

★ ★ ★ ☆ ☆

Endosense has announced enrollment completion in the EFFICAS I clinical study of its TactiCath contact force-sensing ablation catheter.

Endosense Completes Enrollment in EFFICAS I Clinical Study

Endosense | DAIC

★ ★ ★ ★ ★

Endosense Completes Enrollment in FDA Study of Force-Sensing Ablation Catheter June 15, 2012 —Endosense, a pioneer and leader in force-sensing technology focused on …

Endosense | DAIC

Endosense Enrolls First Patients in ProForce, an ...

★ ★ ☆ ☆ ☆

6/15/2010 · Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced enrollment of the first patients in its ProForce Registry. The news marks the launch of the ProForce Registry Study, an international, single arm, multi-center, post-market trial of Endosense’s TactiCath force ...

Endosense Enrolls First Patients in ProForce, an ...

Endosense Launches Safety Study of TactiCath System for ...

★ ★ ☆ ☆ ☆

October 9, 2008 – Endosense this week launched the TOCCATA (TOuCh for CATheter Ablation) clinical study to evaluate the safety of the TactiCath system for the treatment of atrial arrhythmias, with enrollment gaining momentum. TOCCATA is a 70 patient European multi-center safety study.

Endosense Launches Safety Study of TactiCath System for ...

Endosense Enrolls First Patients in ProForce, an ...

★ ★ ☆ ☆ ☆

The news marks the launch of the ProForce Registry Study, an international, single arm, multi-center, post-market trial of Endosense’s TactiCath force-sensing ablation catheter. Designed to enroll up to 2,000 patients, the ProForce Registry Study will evaluate the use and impact of contact force monitoring during catheter ablation procedures.

Endosense Enrolls First Patients in ProForce, an ...

Endosense (@TactiCath) | Twitter

★ ★ ☆ ☆ ☆

The latest Tweets from Endosense (@TactiCath). Endosense, a swiss-based medical technology company, pioneered the use of #ContactForce in #catheter ablation for treatment of #afib with its TactiCath catheter. Geneva, Switzerland

Endosense (@TactiCath) | Twitter

Endosense launches ProForce Registry Study of TactiCath ...

★ ★ ☆ ☆ ☆

6/15/2010 · The news marks the launch of the ProForce Registry Study, an international, single arm, multi-center, post-market trial of Endosense's TactiCath force-sensing ablation catheter.

Endosense launches ProForce Registry Study of TactiCath ...

Endosense announces completion of enrollment in EFFICAS I ...

★ ★ ★ ☆ ☆

2/16/2011 · The next study in the EFFICAS series is EFFICAS II, in which investigators will take full advantage of the real-time, objective TactiCath contact force control features to improve their ablation ...

Endosense announces completion of enrollment in EFFICAS I ...

Endosense Unveils TOCCATA Trial Results | EP Lab Digest

★ ★ ★ ★ ☆

5/18/2009 · Endosense has announced the release of acute clinical results from the TOCCATA (TOuCh+ for CATheter Ablation) European clinical trial at Heart Rhythm 2009, the Heart Rhythm Society’s 30th Annual Scientific Sessions in Boston, May 13-16. The highly anticipated results of the 76-patient, multi-center study confirm the feasibility, safety and value of Endosense’s TactiCath force-sensing ...

Endosense Unveils TOCCATA Trial Results | EP Lab Digest

TOCCATA - Touch+™ for Catheter Ablation - Full Text View ...

★ ★ ★ ★ ★

10/19/2010 · The main objective of this study is to demonstrate the clinical safety of a contact force sensing RF ablation catheter when used for the treatment of supraventricular tachycardia and atrial fibrillation. In addition, the study will characterize the use and …

TOCCATA - Touch+™ for Catheter Ablation - Full Text View ...

TactiCath® Prospective Effectiveness Pilot Study - Full ...

★ ★ ★ ★ ★

5/6/2014 · TactiCath® Prospective Effectiveness Pilot Study (EFFICAS II) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. ... Endosense. More Information.

TactiCath® Prospective Effectiveness Pilot Study - Full ...

Endosense Launches TactiCath® 75 Force-Sensing Catheter ...

★ ★ ★ ★ ★

January 15, 2012: Endosense Launches TactiCath® 75 Force-Sensing Catheter, Announces New Results of EFFICAS I Clinical Study. Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced the European launch of the TactiCath 75 force-sensing ablation catheter as well as ...

Endosense Launches TactiCath® 75 Force-Sensing Catheter ...

Endosense Underscores Significance of Contact Force ...

★ ★ ☆ ☆ ☆

5/13/2013 · Endosense Underscores Significance of Contact Force Parameters with New Study Data at Heart Rhythm 2013 ... Endosense's TactiCath ablation catheter could enhance the capabilities of …

Endosense Underscores Significance of Contact Force ...

Endosense Launches TOCCATA Clinical Study - Newswise

★ ★ ★ ☆ ☆

Endosense, a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac rhythm disorders, has launched the TOCCATA (TOuCh+ for CATheter ...

Endosense Launches TOCCATA Clinical Study - Newswise

New Technologies for AF Ablation: Do they add value ...

★ ★ ★ ★ ☆

New Technologies for AF Ablation: Do they add value? Contact Force Ablation Catheters Karl-Heinz Kuck Hanseatic Heart Center St. Georg Hospital in Hamburg, Germany

New Technologies for AF Ablation: Do they add value ...

BIOTRONIK congratulates Endosense on the FDA IDE approval ...

★ ★ ★ ★ ☆

1/13/2011 · BIOTRONIK congratulates Endosense on the FDA IDE approval of the TOCCASTAR clinical trial and first patient enrollment Jan 13, 2011 11:24am Important achievement for …

BIOTRONIK congratulates Endosense on the FDA IDE approval ...

Endosense Launches TOCCATA Clinical Study | BioSpace

★ ★ ★ ★ ★

GENEVA--(BUSINESS WIRE)--Endosense, a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac rhythm disorders, has launched the TOCCATA (TOuCh+ for CATheter Ablation) clinical study to evaluate the safety of the TactiCath™ system with enrollment gaining momentum.

Endosense Launches TOCCATA Clinical Study | BioSpace

Endosense’s EFFICAS I Study Yields New Contact Force ...

★ ★ ☆ ☆ ☆

Endosense’s EFFICAS I Study Yields New Contact Force Guidelines in Catheter Ablation Treatment of AF ... Investigators performed the procedure with Endosense’s TactiCath, the first force-sensing catheter to give the electrophysiologist a real-time, objective measure of …

Endosense’s EFFICAS I Study Yields New Contact Force ...
China-nz-fta-mfat-study.html,China-study-deutsch-download.html,Chipotle-case-study-strategic-management.html,Chlorhexidine-gluconate-drug-study.html,Christianson-and-hubinette-study.html